Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity

Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brai...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 49; no. 9; pp. 1481 - 1490
Main Authors Karunakaran, Keerthana Deepti, Pascale, Michael, Ozana, Nisan, Potter, Kevin, Pachas, Gladys N., Evins, A. Eden, Gilman, Jodi M.
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.08.2024
Springer International Publishing
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18–55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10–80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings ( ES  = 35.30, p  < 0.001) and heart rate ( ES  = 11.15, p  = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r  = 0.32, p  < 0.001; RSFC between bilateral mPFC and DEQ scores, r = –0.28, p  = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p  = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073–0.1 Hz frequency range at p  < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).
AbstractList Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18-55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10-80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = -0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073-0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).
Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18-55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10-80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = -0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073-0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18-55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10-80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = -0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073-0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).
Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18–55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10–80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings ( ES  = 35.30, p  < 0.001) and heart rate ( ES  = 11.15, p  = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r  = 0.32, p  < 0.001; RSFC between bilateral mPFC and DEQ scores, r = –0.28, p  = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p  = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073–0.1 Hz frequency range at p  < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).
Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of Δ9-tetrahydrocannabinol (THC), the primary intoxicating cannabinoid in cannabis, are densely localized within prefrontal cortex; therefore, prefrontal brain regions are key locations to examine brain changes that characterize acute intoxication. We conducted a double-blind, randomized, cross-over study in adults, aged 18–55 years, who use cannabis regularly, to determine the effects of acute intoxication on prefrontal cortex resting-state measures, assessed with portable functional near-infrared spectroscopy. Participants received oral THC (10–80 mg, individually dosed to overcome tolerance and achieve acute intoxication) and identical placebo, randomized for order; 185 adults were randomized and 128 completed both study days and had usable data. THC was associated with expected increases in subjective intoxication ratings (ES = 35.30, p < 0.001) and heart rate (ES = 11.15, p = 0.001). THC was associated with decreased correlations and anticorrelations in static resting-state functional connectivity within the prefrontal cortex relative to placebo, with weakest correlations and anticorrelations among those who reported greater severity of intoxication (RSFC between medial PFC-ventromedial PFC and DEQ scores, r = 0.32, p < 0.001; RSFC between bilateral mPFC and DEQ scores, r = –0.28, p = 0.001). Relative to placebo, THC was associated with increased variability (or reduced stability) in dynamic resting-state functional connectivity of the prefrontal cortex at p = 0.001, consistent across a range of window sizes. Finally, using frequency power spectrum analyses, we observed that relative to placebo, THC was associated with widespread reduced spectral power within the prefrontal cortex across the 0.073–0.1 Hz frequency range at p < 0.039. These neural features suggest a disruptive influence of THC on the neural dynamics of the prefrontal cortex and may underlie cognitive impairing effects of THC that are detectable with portable imaging. This study is registered in Clinicaltrials.gov (NCT03655717).
Author Gilman, Jodi M.
Pachas, Gladys N.
Potter, Kevin
Evins, A. Eden
Pascale, Michael
Ozana, Nisan
Karunakaran, Keerthana Deepti
Author_xml – sequence: 1
  givenname: Keerthana Deepti
  surname: Karunakaran
  fullname: Karunakaran, Keerthana Deepti
– sequence: 2
  givenname: Michael
  orcidid: 0000-0002-4381-224X
  surname: Pascale
  fullname: Pascale, Michael
– sequence: 3
  givenname: Nisan
  surname: Ozana
  fullname: Ozana, Nisan
– sequence: 4
  givenname: Kevin
  surname: Potter
  fullname: Potter, Kevin
– sequence: 5
  givenname: Gladys N.
  surname: Pachas
  fullname: Pachas, Gladys N.
– sequence: 6
  givenname: A. Eden
  surname: Evins
  fullname: Evins, A. Eden
– sequence: 7
  givenname: Jodi M.
  orcidid: 0000-0001-5180-6694
  surname: Gilman
  fullname: Gilman, Jodi M.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38714786$$D View this record in MEDLINE/PubMed
BookMark eNp9kc9OXCEYxUljU0ftC3RhSLpxg_If7soY01YTEzc1cUe4XKaDuQMjcI3T5_C5-kxFR0110RUhnHM43_fbAVsxRQ_AF4IPCWb6qHDCtESYcoSJVhKJD2BGFMdIMn69BWZYdwwRxq63wU4pNxgToaT-BLaZVoQrLWfAn8ea7oOzNaQIh8nDmuCfhw5VX7NdrIecnI3R9iGmEYYC3cJm66rP4bcfYL-GQyh5WtV2WWU_zylWO0KXcvX3sAnDXajrPfBxbsfiPz-fu-Dq-7efp2fo4vLH-enJBXKckYoGTWjHyKAcx6pzTNJOUSFpL-hczZ2j1g6US9JhJTClPXUMa2kZ9710WnZsFxxvcldTv_SD87ENMZpVDkub1ybZYN6-xLAwv9KdIYQKQpRuCQfPCTndTr5UswzF-XG00aepGIYFFZ2Q-vGzr--kN2nKsc3XVBo3IEriptr_t9JrlxcETaA3ApdTKW2FxoX6hKM1DKMh2DzSNhvaptE2T7SNaFb6zvqS_h_TXwAPrpo
CitedBy_id crossref_primary_10_1124_jpet_123_001987
Cites_doi 10.1016/j.neuroimage.2009.09.037
10.1016/0013-4694(87)90206-9
10.1038/nature20153
10.21037/tp-21-412
10.1016/j.neubiorev.2009.07.008
10.1093/brain/awad389
10.1111/nyas.13948
10.3389/fnhum.2016.00216
10.1111/adb.12870
10.31707/VDR2019.5.1.p31
10.1017/S1461145711000526
10.1364/AO.48.00D280
10.1001/archgenpsychiatry.2011.161
10.1016/S1566-0702(01)00289-2
10.1007/BF02447083
10.1371/journal.pone.0053127
10.3389/fnhum.2017.00258
10.1088/0967-3334/31/5/004
10.2174/138161210791293097
10.1371/journal.pone.0070074
10.1038/s41386-021-01259-0
10.1177/0269881119841568
10.1007/978-3-030-32254-0_17
10.1111/j.2517-6161.1995.tb02031.x
10.1016/j.neuroimage.2019.05.012
10.1038/s41386-024-01809-2
10.1002/j.1552-4604.2002.tb06005.x
10.1097/00007691-199810000-00021
10.3390/a11050067
10.1007/s00213-012-2954-z
10.1007/s12021-020-09500-9
10.1038/s41598-022-06509-9
10.3791/53336
10.1093/jat/bkx012
10.1007/s00213-006-0508-y
10.1038/srep17471
10.1016/j.neubiorev.2021.11.004
10.1038/npp.2014.258
10.1002/hbm.22140
10.1016/j.euroneuro.2018.12.003
10.1001/jamapsychiatry.2023.2309
10.1016/j.neubiorev.2021.01.003
10.3389/fnhum.2017.00488
10.1111/psyp.13955
10.1080/15389588.2020.1851685
10.1016/j.nicl.2016.05.011
10.1007/s11682-015-9488-z
10.1371/journal.pone.0052545
10.1016/j.euroneuro.2014.11.018
10.1007/s00213-007-0940-7
10.1016/j.neuroimage.2007.02.041
10.1038/s41583-021-00466-4
10.3389/fpsyt.2021.689444
10.1016/j.euroneuro.2020.01.006
10.1093/schbul/sbv064
10.1093/cercor/bhj136
10.1016/j.neuroscience.2016.09.034
10.1016/j.neuroimage.2012.03.070
10.1016/j.neuroimage.2012.01.044
10.3389/fnins.2019.01430
10.1016/j.neuroimage.2012.11.038
10.1073/pnas.1422487112
ContentType Journal Article
Copyright 2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/s41386-024-01876-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef
ProQuest One Psychology

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1740-634X
EndPage 1490
ExternalDocumentID PMC11251178
38714786
10_1038_s41386_024_01876_5
Genre Randomized Controlled Trial
Journal Article
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: R42 DA043977
– fundername: NIDA NIH HHS
  grantid: K02 DA052684
– fundername: NIDA NIH HHS
  grantid: K24 DA030443
– fundername: NIDA NIH HHS
  grantid: R01 DA042043
GroupedDBID ---
-DZ
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
F5P
FDB
FDQFY
FIGPU
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M1P
M2M
M7P
NADUK
NQJWS
NXXTH
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOJ
SRMVM
SWTZT
TAOOD
TR2
UKHRP
W2D
ZGI
--K
-Q-
1B1
53G
5VS
AAEDT
AALRI
AAQFI
AAQXK
AAXUO
ABMAC
ABWVN
ACIUM
ACRPL
ACRQY
ADMUD
ADNMO
CAG
CGR
COF
CUY
CVF
ECM
EIF
EIOEI
EJD
EMB
EMOBN
FEDTE
FERAY
FGOYB
FIZPM
FSGXE
HVGLF
IHE
M41
MK0
NPM
NQ-
R2-
RIG
RNS
RPZ
SEW
SOHCF
SSZ
SV3
TBHMF
TDRGL
ZKB
3V.
7TK
7XB
8FE
8FH
8FK
ABRTQ
K9.
LK8
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c431t-d812931d7c4079c362972562b52f7fcc2aad24619075022b2c3086a34eb6c8693
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 18:33:03 EDT 2025
Fri Jul 11 16:03:48 EDT 2025
Sat Aug 23 12:44:04 EDT 2025
Thu Apr 03 07:09:13 EDT 2025
Tue Jul 01 01:05:47 EDT 2025
Thu Apr 24 23:07:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
License 2024. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c431t-d812931d7c4079c362972562b52f7fcc2aad24619075022b2c3086a34eb6c8693
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ORCID 0000-0001-5180-6694
0000-0002-4381-224X
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC11251178
PMID 38714786
PQID 3080876760
PQPubID 33935
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11251178
proquest_miscellaneous_3052595689
proquest_journals_3080876760
pubmed_primary_38714786
crossref_citationtrail_10_1038_s41386_024_01876_5
crossref_primary_10_1038_s41386_024_01876_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-08-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: New York
– name: Cham
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2024
Publisher Nature Publishing Group
Springer International Publishing
Publisher_xml – name: Nature Publishing Group
– name: Springer International Publishing
References Y Benjamini (1876_CR47) 1995; 57
JG Ramaekers (1876_CR6) 2021; 22
JM Gilman (1876_CR21) 2019; 197
NL Mason (1876_CR50) 2021; 26
GD Pearlson (1876_CR10) 2021; 12
TR Arkell (1876_CR12) 2021; 22
U Braun (1876_CR56) 2015; 112
D McCartney (1876_CR61) 2022; 134
RW Homan (1876_CR36) 1987; 66
F Scholkmann (1876_CR40) 2010; 31
M van Schouwenburg (1876_CR8) 2010; 16
1876_CR63
1876_CR20
E Pabon (1876_CR58) 2022; 59
SM Eggan (1876_CR1) 2006; 17
R Vandrey (1876_CR64) 2017; 41
R Levy (1876_CR7) 2023; 147
JG Ramaekers (1876_CR4) 2016; 10
MAP Bloomfield (1876_CR27) 2016; 539
NL Mason (1876_CR28) 2019; 29
T Mei (1876_CR46) 2022; 11
XN Zuo (1876_CR44) 2010; 49
JG Ramaekers (1876_CR62) 2023; 80
JM Gilman (1876_CR13) 2022; 47
P Pinti (1876_CR17) 2015; 5
S Sidney (1876_CR59) 2002; 42
JG Ramaekers (1876_CR26) 2022; 12
A Weinstein (1876_CR2) 2008; 196
L Douw (1876_CR55) 2016; 339
D McCartney (1876_CR11) 2021; 126
SA Meda (1876_CR45) 2015; 41
MB Wall (1876_CR25) 2019; 33
1876_CR33
ZQ Gong (1876_CR57) 2021; 19
M Ranganathan (1876_CR5) 2006; 188
GJ Thompson (1876_CR53) 2013; 34
1876_CR9
M Cope (1876_CR39) 1988; 26
CW Myers (1876_CR60) 2001; 91
L Hocke (1876_CR38) 2018; 11
AZ Snyder (1876_CR41) 2012; 62
MA Huestis (1876_CR34) 1998; 20
JB Balardin (1876_CR15) 2017; 11
JM Gilman (1876_CR23) 2022; 47
ME Raichle (1876_CR24) 2007; 37
S Bhattacharyya (1876_CR49) 2012; 69
P Pinti (1876_CR18) 2020; 1464
R McKendrick (1876_CR16) 2016; 10
F Zhou (1876_CR43) 2017; 15
HH van Hell (1876_CR51) 2011; 14
ME Morean (1876_CR35) 2013; 227
I Cribben (1876_CR32) 2012; 61
MG Bossong (1876_CR31) 2013; 8
Y Zhang (1876_CR42) 2020; 13
WM Bosker (1876_CR3) 2013; 8
S Bhattacharyya (1876_CR30) 2015; 25
C Chang (1876_CR54) 2013; 68
HO Keles (1876_CR22) 2017; 11
S Bhattacharyya (1876_CR29) 2015; 40
JG Ramaekers (1876_CR14) 2020; 36
1876_CR52
G Battistella (1876_CR48) 2013; 8
S Lloyd-Fox (1876_CR19) 2010; 34
TJ Huppert (1876_CR37) 2009; 48
References_xml – volume: 49
  start-page: 1432
  year: 2010
  ident: 1876_CR44
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2009.09.037
– volume: 66
  start-page: 376
  year: 1987
  ident: 1876_CR36
  publication-title: Electroencephalogr Clin Neurophysiol
  doi: 10.1016/0013-4694(87)90206-9
– volume: 539
  start-page: 369
  year: 2016
  ident: 1876_CR27
  publication-title: Nature
  doi: 10.1038/nature20153
– volume: 11
  start-page: 349
  year: 2022
  ident: 1876_CR46
  publication-title: Transl Pediatr
  doi: 10.21037/tp-21-412
– volume: 34
  start-page: 269
  year: 2010
  ident: 1876_CR19
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2009.07.008
– volume: 147
  start-page: 794
  year: 2023
  ident: 1876_CR7
  publication-title: Brain
  doi: 10.1093/brain/awad389
– volume: 1464
  start-page: 5
  year: 2020
  ident: 1876_CR18
  publication-title: Ann NY Acad Sci
  doi: 10.1111/nyas.13948
– volume: 10
  start-page: 216
  year: 2016
  ident: 1876_CR16
  publication-title: Front Hum Neurosci
  doi: 10.3389/fnhum.2016.00216
– volume: 26
  start-page: e12870
  year: 2021
  ident: 1876_CR50
  publication-title: Addiction Biol
  doi: 10.1111/adb.12870
– ident: 1876_CR63
  doi: 10.31707/VDR2019.5.1.p31
– volume: 14
  start-page: 1377
  year: 2011
  ident: 1876_CR51
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145711000526
– volume: 48
  start-page: D280
  year: 2009
  ident: 1876_CR37
  publication-title: Appl Opt
  doi: 10.1364/AO.48.00D280
– volume: 69
  start-page: 27
  year: 2012
  ident: 1876_CR49
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.161
– volume: 91
  start-page: 62
  year: 2001
  ident: 1876_CR60
  publication-title: Auton Neurosci
  doi: 10.1016/S1566-0702(01)00289-2
– volume: 26
  start-page: 289
  year: 1988
  ident: 1876_CR39
  publication-title: Med Biol Eng Comput
  doi: 10.1007/BF02447083
– volume: 8
  start-page: e53127
  year: 2013
  ident: 1876_CR3
  publication-title: Plos One
  doi: 10.1371/journal.pone.0053127
– volume: 11
  start-page: 258
  year: 2017
  ident: 1876_CR15
  publication-title: Front Hum Neurosci
  doi: 10.3389/fnhum.2017.00258
– volume: 31
  start-page: 649
  year: 2010
  ident: 1876_CR40
  publication-title: Physiol Meas
  doi: 10.1088/0967-3334/31/5/004
– volume: 16
  start-page: 2026
  year: 2010
  ident: 1876_CR8
  publication-title: Curr Pharm Des
  doi: 10.2174/138161210791293097
– volume: 8
  start-page: e70074
  year: 2013
  ident: 1876_CR31
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0070074
– volume: 47
  start-page: 944
  year: 2022
  ident: 1876_CR23
  publication-title: Neuropsychopharmacology
  doi: 10.1038/s41386-021-01259-0
– volume: 33
  start-page: 822
  year: 2019
  ident: 1876_CR25
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881119841568
– ident: 1876_CR33
  doi: 10.1007/978-3-030-32254-0_17
– volume: 57
  start-page: 289
  year: 1995
  ident: 1876_CR47
  publication-title: J R Stat Soc, Ser B
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 197
  start-page: 575
  year: 2019
  ident: 1876_CR21
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2019.05.012
– ident: 1876_CR52
  doi: 10.1038/s41386-024-01809-2
– volume: 42
  start-page: 64S
  year: 2002
  ident: 1876_CR59
  publication-title: J Clin Pharm
  doi: 10.1002/j.1552-4604.2002.tb06005.x
– volume: 20
  start-page: 570
  year: 1998
  ident: 1876_CR34
  publication-title: Ther Drug Monit
  doi: 10.1097/00007691-199810000-00021
– volume: 11
  start-page: 67
  year: 2018
  ident: 1876_CR38
  publication-title: Algorithms
  doi: 10.3390/a11050067
– volume: 227
  start-page: 177
  year: 2013
  ident: 1876_CR35
  publication-title: Psychopharmacol (Berl)
  doi: 10.1007/s00213-012-2954-z
– volume: 47
  start-page: 944
  year: 2022
  ident: 1876_CR13
  publication-title: Neuropsychopharmacology
  doi: 10.1038/s41386-021-01259-0
– volume: 19
  start-page: 529
  year: 2021
  ident: 1876_CR57
  publication-title: Neuroinformatics
  doi: 10.1007/s12021-020-09500-9
– volume: 12
  year: 2022
  ident: 1876_CR26
  publication-title: Sci Rep.
  doi: 10.1038/s41598-022-06509-9
– ident: 1876_CR20
  doi: 10.3791/53336
– volume: 41
  start-page: 83
  year: 2017
  ident: 1876_CR64
  publication-title: J Anal Toxicol
  doi: 10.1093/jat/bkx012
– volume: 188
  start-page: 425
  year: 2006
  ident: 1876_CR5
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-006-0508-y
– volume: 5
  year: 2015
  ident: 1876_CR17
  publication-title: Sci Rep.
  doi: 10.1038/srep17471
– volume: 134
  start-page: 104433
  year: 2022
  ident: 1876_CR61
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2021.11.004
– volume: 40
  start-page: 1343
  year: 2015
  ident: 1876_CR29
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2014.258
– volume: 34
  start-page: 3280
  year: 2013
  ident: 1876_CR53
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.22140
– volume: 29
  start-page: 247
  year: 2019
  ident: 1876_CR28
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2018.12.003
– volume: 80
  start-page: 871
  year: 2023
  ident: 1876_CR62
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2023.2309
– volume: 126
  start-page: 175
  year: 2021
  ident: 1876_CR11
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2021.01.003
– volume: 11
  start-page: 488
  year: 2017
  ident: 1876_CR22
  publication-title: Front Hum Neurosci
  doi: 10.3389/fnhum.2017.00488
– volume: 59
  start-page: e13955
  year: 2022
  ident: 1876_CR58
  publication-title: Psychophysiology
  doi: 10.1111/psyp.13955
– volume: 22
  start-page: 102
  year: 2021
  ident: 1876_CR12
  publication-title: Traffic Inj Prev
  doi: 10.1080/15389588.2020.1851685
– volume: 15
  start-page: 458
  year: 2017
  ident: 1876_CR43
  publication-title: Neuroimage Clin
  doi: 10.1016/j.nicl.2016.05.011
– volume: 10
  start-page: 1254
  year: 2016
  ident: 1876_CR4
  publication-title: Brain Imaging Behav
  doi: 10.1007/s11682-015-9488-z
– volume: 8
  start-page: e52545
  year: 2013
  ident: 1876_CR48
  publication-title: Plos One
  doi: 10.1371/journal.pone.0052545
– volume: 25
  start-page: 26
  year: 2015
  ident: 1876_CR30
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2014.11.018
– volume: 196
  start-page: 119
  year: 2008
  ident: 1876_CR2
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-007-0940-7
– volume: 37
  start-page: 1083
  year: 2007
  ident: 1876_CR24
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2007.02.041
– ident: 1876_CR9
– volume: 22
  start-page: 439
  year: 2021
  ident: 1876_CR6
  publication-title: Nat Rev Neurosci
  doi: 10.1038/s41583-021-00466-4
– volume: 12
  start-page: 689444
  year: 2021
  ident: 1876_CR10
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2021.689444
– volume: 36
  start-page: 191
  year: 2020
  ident: 1876_CR14
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2020.01.006
– volume: 41
  start-page: 1336
  year: 2015
  ident: 1876_CR45
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbv064
– volume: 17
  start-page: 175
  year: 2006
  ident: 1876_CR1
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/bhj136
– volume: 339
  start-page: 12
  year: 2016
  ident: 1876_CR55
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2016.09.034
– volume: 61
  start-page: 907
  year: 2012
  ident: 1876_CR32
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2012.03.070
– volume: 62
  start-page: 902
  year: 2012
  ident: 1876_CR41
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2012.01.044
– volume: 13
  start-page: 1430
  year: 2020
  ident: 1876_CR42
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2019.01430
– volume: 68
  start-page: 93
  year: 2013
  ident: 1876_CR54
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2012.11.038
– volume: 112
  start-page: 11678
  year: 2015
  ident: 1876_CR56
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1422487112
SSID ssj0015768
Score 2.4675992
Snippet Neural states of impairment from intoxicating substances, including cannabis, are poorly understood. Cannabinoid 1 receptors, the main target of...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1481
SubjectTerms Acute intoxication
Adolescent
Adult
Cannabinoid Receptor Agonists - administration & dosage
Cannabinoid Receptor Agonists - pharmacology
Cannabinoid receptors
Cannabinoids
Cannabis
Cross-Over Studies
Double-Blind Method
Dronabinol - administration & dosage
Dronabinol - pharmacology
Female
Heart rate
Heart Rate - drug effects
Humans
Infrared spectroscopy
Intoxication
Male
Marijuana
Middle Aged
Neural networks
Neuroimaging
Placebos
Prefrontal cortex
Prefrontal Cortex - drug effects
Spectroscopy, Near-Infrared
Tetrahydrocannabinol
THC
Young Adult
Title Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity
URI https://www.ncbi.nlm.nih.gov/pubmed/38714786
https://www.proquest.com/docview/3080876760
https://www.proquest.com/docview/3052595689
https://pubmed.ncbi.nlm.nih.gov/PMC11251178
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB5BKyEuCLb8BEplJNQLtbpJHMc5oQKtWhBVhVppb5Fje9WVSrI0WanLc_BcPBMzjjdlQeoxsp04mvHMN_b4G4C3LlNT4aTieSYtF5UQvNBWcSeTyuhCj6X22Ran8vhCfJ5kk7Dh1oa0ypVN9IbaNob2yPdThDa4cnM5fj__walqFJ2uhhIa92GTqMtIq_PJEHDFhKU9iixSjrHYJFyaGadqv0XjrSj9lnIw8L08W3dM_6HNf5Mm__JCR4_hUYCP7KCX9xO45-oRbB3UGDp_X7Jd5hM6_U75CB58DefmI9g96xmql3vs_PbCVbvnRwzc1cstcCd119yEfTxmF451Dfv9q-Cdw-lcLi36O13XGuPp5orNWmYGwuefzrJqyeysvV7MEceyOf4j0SPgfA2l9N4wukRBtSqewsXR4fnHYx4qMXCDAKPjVhEsiG1uMP4rDDq9IkeslFRZMs2nxiRaWyKmKwiAJEmVGBSX1KlwlTRKFukz2Kib2r0AZlKX4EAnppUUyhrt0MKNhXAIfLCrjSBeiaE0gaacqmVclf64PFVlL7oSRVd60ZVZBO-GMfOepOPO3tsr6ZZhwbblrXpF8GZoxqVG5ye6ds2C-mQYLGZSFRE875Vh-FyKgafIlYxAranJ0IFovNdb6tmlp_OOCWPGuXp597xewcPEqyslH27DRne9cK8REHXVjtf6Hdj8cHh69g2fPp18-QPg5Qz9
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIgEXBFugWwoYCXqhVrOO4zgHhCqg2qU_4rCV9hYc26uuVJJtkxUNz8Fz8Cg8EzNONmVB6q1n27GjGc_MZ4-_IeS1i9RUOKlYHEnLRCYES7RVzEmeGZ3oQGqfbXEih6fi8ySarJFfy7cwmFa5tIneUNvC4Bn5XgihDezcWAbv5xcMq0bh7eqyhEajFoeu_g6QrXw3-gjyfcP5wafxhyFrqwowA86yYlahixvY2ACWSQwY8CQGv8-ziE_jqTFca4skawk6U84zbmBqqUPhMmmURPIlMPl34FsBgr140gG8AcbuPmpNQgbYb9I-0glCtVeCs1CY7os5H_AfLFp1hP9Ft_8maf7l9Q4ekgdtuEr3G_16RNZc3iMb-zlA9W813aE-gdSfzPfI3eP2nr5Hdr40jNj1Lh1fP_Aqd_2Ijiu73iBulFfFVXtuSO3C0aqgv38mrHKwnLPagn_Vea4BvxfndFZS0xFM_3CWZjW1s_JyMYe4mc7hH5GOAdZrMIX4iuKjDayN8Zic3oqMnpD1vMjdJqEmdBwGOjHNpFDWaAcWNRDCQaAFXW2fDJZiSE1Li47VOc5Tfz0fqrQRXQqiS73o0qhP3nZj5g0pyI29t5fSTVsDUabX6twnr7pm2Np4X6NzVyywTwTgNJIq6ZOnjTJ004UAdEWsZJ-oFTXpOiBt-GpLPjvz9OEDjGkHsdq6eV0vyb3h-PgoPRqdHD4j97lXXUx83Cbr1eXCPYdgrMpe-B1Aydfb3nJ_AKaQRLs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLamTpq4QdDxkzHASLAbZrV1HMe5QGiwVSuDqkKb1Lvg2K5WaSRlScXCc_A0PATPxDlJmlGQdrdr24qj8_cdn-PPhLx0gZoJJxULA2mZSIRgkbaKOckToyPdl7rqthjL4zPxYRpMN8iv1V0YbKtc-cTKUdvM4Bl5zwdoA5Ybyn5v1rRFTA6HbxffGL4ghZXW1XMatYqcuPI7pG_5m9EhyPoV58Oj0_fHrHlhgBkInAWzCsPdwIYG8prIgDOPQsAAPAn4LJwZw7W2SLgWYWDlPOEGtiG1L1wijZJIxATufzPErKhDNt8djSef2xoGIvkKw0Y-g0xw2lzZ6fuql0PoUNj8ix0g8FcsWA-L_2Hdf1s2_4qBw3vkbgNe6UGtbffJhku7ZPsghcT9a0n3aNVOWp3Td8nWp6Zq3yV7k5ofu9ynp9fXvfL9akXLnF1uEzdKi-yqOUWkdulokdHfPyNWONjOeWkh2uo01ZDNZxd0nlPT0k3_cJYmJbXz_HK5ABRNF_CPSM4A-zXYUHxF8QoHvpTxgJzdipQekk6ape4xocZ3HBY6MUukUNZoB_61L4QD2AVTrUcGKzHEpiFJx7c6LuKqWO-ruBZdDKKLK9HFgUdet2sWNUXIjbN3V9KNG3eRx9fK7ZEX7TAYOlZvdOqyJc4JIFUNpIo88qhWhvZzPqS9IlTSI2pNTdoJSCK-PpLOzysy8QEi3EGodm7e13OyBeYWfxyNT56QO7zSXOyC3CWd4nLpngIyK5JnjQlQ8uW2re4PbIBKVg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intoxication+due+to+%CE%949-tetrahydrocannabinol+is+characterized+by+disrupted+prefrontal+cortex+activity&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Karunakaran%2C+Keerthana+Deepti&rft.au=Pascale%2C+Michael&rft.au=Ozana%2C+Nisan&rft.au=Potter%2C+Kevin&rft.date=2024-08-01&rft.issn=1740-634X&rft.eissn=1740-634X&rft.volume=49&rft.issue=9&rft.spage=1481&rft_id=info:doi/10.1038%2Fs41386-024-01876-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon